Skip to main content
. 2019 Jul 15;11(7):4100–4112.

Figure 7.

Figure 7

The expression and quantification of PAK 1 (A), ROCK2 (B), LIMK 1 (C) and Cofilin (D) in ADSCs treated with PRP plus the Cdc 42 inhibitor ZCL278, the PAK inhibitor FRAX597, the Rho A inhibitor CT04, the Rock 2 inhibitor Y27632 or Rac 1 inhibitor NSC23766. Untreated cells served as controls.